Infliximab, brand Remicade, is dosed by intravenous infusion at which rate per kilogram?

Prepare for the Dermatology Week 1 Exam with comprehensive study materials. Practice with detailed questions, flashcards, and expert explanations. Boost your knowledge and confidence for the exam!

Multiple Choice

Infliximab, brand Remicade, is dosed by intravenous infusion at which rate per kilogram?

Explanation:
Infliximab is a monoclonal antibody given by intravenous infusion, with dosing calculated based on patient body weight. The standard dose for each infusion is 5 mg per kilogram of body weight, typically given on a schedule that starts with three infusions (at weeks 0, 2, and 6) for induction and then every 8 weeks for maintenance. This makes the per-kilogram dose clear: 5 mg for every kilogram the patient weighs. Remicade is delivered only by IV infusion; it is not given subcutaneously. The other options misstate either the route or the drug: a subcutaneous formulation is used for other TNF inhibitors, and Cimzia and Humira are not IV infusions of infliximab. Therefore, the correct description is Remicade given IV at 5 mg/kg.

Infliximab is a monoclonal antibody given by intravenous infusion, with dosing calculated based on patient body weight. The standard dose for each infusion is 5 mg per kilogram of body weight, typically given on a schedule that starts with three infusions (at weeks 0, 2, and 6) for induction and then every 8 weeks for maintenance. This makes the per-kilogram dose clear: 5 mg for every kilogram the patient weighs.

Remicade is delivered only by IV infusion; it is not given subcutaneously. The other options misstate either the route or the drug: a subcutaneous formulation is used for other TNF inhibitors, and Cimzia and Humira are not IV infusions of infliximab. Therefore, the correct description is Remicade given IV at 5 mg/kg.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy